世界のジフテリア・百日咳・破傷風ワクチン市場予測 2021年-2026年

【英語タイトル】Global Diphtheria, Pertussis, and Tetanus Vaccine Market Growth 2021-2026

LP Informationが出版した調査資料(LPI21MY1209)・商品コード:LPI21MY1209
・発行会社(調査会社):LP Information
・発行日:2021年5月(※2024年版があります。お問い合わせください)
・ページ数:133
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:化学&材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
LPインフォメーション社の「ジフテリア・百日咳・破傷風ワクチンの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、DTaP、Td、Tdapなど、用途別には、病院、クリニック、予防接種センターなどにセグメント区分してまとめました。ジフテリア・百日咳・破傷風ワクチンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・ジフテリア・百日咳・破傷風ワクチンの世界市場概要(サマリー)
・ジフテリア・百日咳・破傷風ワクチンの企業別販売量・売上
・ジフテリア・百日咳・破傷風ワクチンの企業別市場シェア
・ジフテリア・百日咳・破傷風ワクチンの世界市場規模 2016年-2021年:種類別(DTaP、Td、Tdap)
・ジフテリア・百日咳・破傷風ワクチンの世界市場規模 2016年-2021年:用途別(病院、クリニック、予防接種センター)
・ジフテリア・百日咳・破傷風ワクチンの南北アメリカ市場規模(アメリカ、カナダ、メキシコなど)
・ジフテリア・百日咳・破傷風ワクチンのアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・ジフテリア・百日咳・破傷風ワクチンのヨーロッパ市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・ジフテリア・百日咳・破傷風ワクチンの中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・ジフテリア・百日咳・破傷風ワクチン市場の成長要因・課題・動向
・ジフテリア・百日咳・破傷風ワクチンの世界市場予測 2021年-2026年
・ジフテリア・百日咳・破傷風ワクチンの南北アメリカ市場予測(アメリカ、カナダ、メキシコなど)
・ジフテリア・百日咳・破傷風ワクチンのアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・ジフテリア・百日咳・破傷風ワクチンのヨーロッパ市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・ジフテリア・百日咳・破傷風ワクチンの中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・ジフテリア・百日咳・破傷風ワクチンの世界市場予測:種類別(DTaP、Td、Tdap)
・ジフテリア・百日咳・破傷風ワクチンの世界市場予測:用途別(病院、クリニック、予防接種センター)
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Diphtheria, Pertussis, and Tetanus Vaccine will have significant change from previous year. By the most conservative estimates of global Diphtheria, Pertussis, and Tetanus Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 2467.1 million in 2019. Over the next five years the Diphtheria, Pertussis, and Tetanus Vaccine market will register a 4.0% CAGR in terms of revenue, the global market size will reach US$ 2886.2 million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Diphtheria, Pertussis, and Tetanus Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
DTaP
Td
Tdap

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospitals
Clinics
Vaccination Centers

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Johnson & Johnson
GlaxoSmithKline
Sanofi
Lanzhou Institute of Biological
Merck
Novartis
AstraZeneca
Emergent
Astellas

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Consumption 2016-2026
2.1.2 Diphtheria, Pertussis, and Tetanus Vaccine Consumption CAGR by Region
2.2 Diphtheria, Pertussis, and Tetanus Vaccine Segment by Type
2.2.1 DTaP
2.2.2 Td
2.2.3 Tdap
2.3 Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type
2.3.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Type (2016-2021)
2.3.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Market Share by Type (2016-2021)
2.3.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Sale Price by Type (2016-2021)
2.4 Diphtheria, Pertussis, and Tetanus Vaccine Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Vaccination Centers
2.5 Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application
2.5.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sale Market Share by Application (2016-2021)
2.5.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Market Share by Application (2016-2021)
2.5.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Sale Price by Application (2016-2021)

3 Global Diphtheria, Pertussis, and Tetanus Vaccine by Company
3.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Company
3.1.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Company (2019-2021)
3.1.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Company (2019-2021)
3.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Company
3.2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Company (2019-2021)
3.2.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Company (2019-2021)
3.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Sale Price by Company
3.4 Global Manufacturers Diphtheria, Pertussis, and Tetanus Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Diphtheria, Pertussis, and Tetanus Vaccine Product Location Distribution
3.4.2 Players Diphtheria, Pertussis, and Tetanus Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Diphtheria, Pertussis, and Tetanus Vaccine by Region
4.1 Global Diphtheria, Pertussis, and Tetanus Vaccine by Region
4.1.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region
4.1.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Region
4.2 Americas Diphtheria, Pertussis, and Tetanus Vaccine Sales Growth
4.3 APAC Diphtheria, Pertussis, and Tetanus Vaccine Sales Growth
4.4 Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales Growth
4.5 Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales Growth

5 Americas
5.1 Americas Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country
5.1.1 Americas Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2016-2021)
5.1.2 Americas Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2016-2021)
5.2 Americas Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type
5.3 Americas Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region
6.1.1 APAC Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2016-2021)
6.1.2 APAC Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Region (2016-2021)
6.2 APAC Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type
6.3 APAC Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Diphtheria, Pertussis, and Tetanus Vaccine by Country
7.1.1 Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2016-2021)
7.1.2 Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2016-2021)
7.2 Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type
7.3 Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine by Country
8.1.1 Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2016-2021)
8.1.2 Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2016-2021)
8.2 Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type
8.3 Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Diphtheria, Pertussis, and Tetanus Vaccine Distributors
10.3 Diphtheria, Pertussis, and Tetanus Vaccine Customer

11 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Forecast
11.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Forecast by Region
11.1.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Forecast by Regions (2021-2026)
11.2.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Diphtheria, Pertussis, and Tetanus Vaccine Forecast by Type
11.7 Global Diphtheria, Pertussis, and Tetanus Vaccine Forecast by Application

12 Key Players Analysis
12.1 Johnson & Johnson
12.1.1 Johnson & Johnson Johnson & Johnson Company Information
12.1.2 Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Product Offered
12.1.3 Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Johnson & Johnson Main Business Overview
12.1.5 Johnson & Johnson Latest Developments
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Company Information
12.2.2 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Product Offered
12.2.3 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 GlaxoSmithKline Main Business Overview
12.2.5 GlaxoSmithKline Latest Developments
12.3 Sanofi
12.3.1 Sanofi Company Information
12.3.2 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Product Offered
12.3.3 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Sanofi Main Business Overview
12.3.5 Sanofi Latest Developments
12.4 Lanzhou Institute of Biological
12.4.1 Lanzhou Institute of Biological Company Information
12.4.2 Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Product Offered
12.4.3 Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Lanzhou Institute of Biological Main Business Overview
12.4.5 Lanzhou Institute of Biological Latest Developments
12.5 Merck
12.5.1 Merck Company Information
12.5.2 Merck Diphtheria, Pertussis, and Tetanus Vaccine Product Offered
12.5.3 Merck Diphtheria, Pertussis, and Tetanus Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Merck Main Business Overview
12.5.5 Merck Latest Developments
12.6 Novartis
12.6.1 Novartis Company Information
12.6.2 Novartis Diphtheria, Pertussis, and Tetanus Vaccine Product Offered
12.6.3 Novartis Diphtheria, Pertussis, and Tetanus Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Novartis Main Business Overview
12.6.5 Novartis Latest Developments
12.7 AstraZeneca
12.7.1 AstraZeneca Company Information
12.7.2 AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Product Offered
12.7.3 AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 AstraZeneca Main Business Overview
12.7.5 AstraZeneca Latest Developments
12.8 Emergent
12.8.1 Emergent Company Information
12.8.2 Emergent Diphtheria, Pertussis, and Tetanus Vaccine Product Offered
12.8.3 Emergent Diphtheria, Pertussis, and Tetanus Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Emergent Main Business Overview
12.8.5 Emergent Latest Developments
12.9 Astellas
12.9.1 Astellas Company Information
12.9.2 Astellas Diphtheria, Pertussis, and Tetanus Vaccine Product Offered
12.9.3 Astellas Diphtheria, Pertussis, and Tetanus Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Astellas Main Business Overview
12.9.5 Astellas Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Diphtheria, Pertussis, and Tetanus Vaccine Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of DTaP
Table 3. Major Players of Td
Table 4. Major Players of Tdap
Table 5. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2016-2021) & (K MT)
Table 6. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Type (2016-2021)
Table 7. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2016-2021) & ($ million)
Table 8. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Type (2016-2021)
Table 9. Global Diphtheria, Pertussis, and Tetanus Vaccine Sale Price by Type (2016-2021)
Table 10. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2016-2021) & (K MT)
Table 11. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Application (2016-2021)
Table 12. Global Diphtheria, Pertussis, and Tetanus Vaccine Value by Application (2016-2021)
Table 13. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Application (2016-2021)
Table 14. Global Diphtheria, Pertussis, and Tetanus Vaccine Sale Price by Application (2016-2021)
Table 15. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Company (2019-2021) & (K MT)
Table 16. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Company (2019-2021)
Table 17. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Company (2019-2021)
Table 19. Global Diphtheria, Pertussis, and Tetanus Vaccine Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Diphtheria, Pertussis, and Tetanus Vaccine Producing Area Distribution and Sales Area
Table 21. Players Diphtheria, Pertussis, and Tetanus Vaccine Products Offered
Table 22. Diphtheria, Pertussis, and Tetanus Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2016-2021) (K MT)
Table 26. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Region (2016-2021)
Table 27. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Region (2016-2021)
Table 29. Americas Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2016-2021) & (K MT)
Table 30. Americas Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Country (2016-2021)
Table 31. Americas Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Country (2016-2021)
Table 33. Americas Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2016-2021) & (K MT)
Table 34. Americas Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Type (2016-2021)
Table 35. Americas Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2016-2021) & (K MT)
Table 36. Americas Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Application (2016-2021)
Table 37. APAC Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2016-2021) & (K MT)
Table 38. APAC Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Region (2016-2021)
Table 39. APAC Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Region (2016-2021)
Table 41. APAC Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2016-2021) & (K MT)
Table 42. APAC Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Type (2016-2021)
Table 43. APAC Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2016-2021) & (K MT)
Table 44. APAC Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Application (2016-2021)
Table 45. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2016-2021) & (K MT)
Table 46. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Country (2016-2021)
Table 47. Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Country (2016-2021)
Table 49. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2016-2021) & (K MT)
Table 50. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Type (2016-2021)
Table 51. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2016-2021) & (K MT)
Table 52. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2016-2021) & (K MT)
Table 54. Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2016-2021) & (K MT)
Table 58. Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2016-2021) & (K MT)
Table 60. Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Application (2016-2021)
Table 61. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Forecast by Type (2021-2026) & (K MT)
Table 62. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 63. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 64. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share Forecast by Type (2021-2026)
Table 65. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Forecast by Application (2021-2026) & (K MT)
Table 66. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share Forecast by Application (2021-2026)
Table 67. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 68. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share Forecast by Application (2021-2026)
Table 69. Johnson & Johnson Basic Information, Diphtheria, Pertussis, and Tetanus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 70. Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Product Offered
Table 71. Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 72. Johnson & Johnson Main Business
Table 73. Johnson & Johnson Latest Developments
Table 74. GlaxoSmithKline Basic Information, Diphtheria, Pertussis, and Tetanus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 75. GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Product Offered
Table 76. GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 77. GlaxoSmithKline Main Business
Table 78. GlaxoSmithKline Latest Developments
Table 79. Sanofi Basic Information, Diphtheria, Pertussis, and Tetanus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 80. Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Product Offered
Table 81. Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 82. Sanofi Main Business
Table 83. Sanofi Latest Developments
Table 84. Lanzhou Institute of Biological Basic Information, Diphtheria, Pertussis, and Tetanus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 85. Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Product Offered
Table 86. Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 87. Lanzhou Institute of Biological Main Business
Table 88. Lanzhou Institute of Biological Latest Developments
Table 89. Merck Basic Information, Diphtheria, Pertussis, and Tetanus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 90. Merck Diphtheria, Pertussis, and Tetanus Vaccine Product Offered
Table 91. Merck Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 92. Merck Main Business
Table 93. Merck Latest Developments
Table 94. Novartis Basic Information, Diphtheria, Pertussis, and Tetanus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 95. Novartis Diphtheria, Pertussis, and Tetanus Vaccine Product Offered
Table 96. Novartis Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 97. Novartis Main Business
Table 98. Novartis Latest Developments
Table 99. AstraZeneca Basic Information, Diphtheria, Pertussis, and Tetanus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 100. AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Product Offered
Table 101. AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 102. AstraZeneca Main Business
Table 103. AstraZeneca Latest Developments
Table 104. Emergent Basic Information, Diphtheria, Pertussis, and Tetanus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 105. Emergent Diphtheria, Pertussis, and Tetanus Vaccine Product Offered
Table 106. Emergent Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 107. Emergent Main Business
Table 108. Emergent Latest Developments
Table 109. Astellas Basic Information, Diphtheria, Pertussis, and Tetanus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 110. Astellas Diphtheria, Pertussis, and Tetanus Vaccine Product Offered
Table 111. Astellas Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 112. Astellas Main Business
Table 113. Astellas Latest Developments
List of Figures
Figure 1. Picture of Diphtheria, Pertussis, and Tetanus Vaccine
Figure 2. Diphtheria, Pertussis, and Tetanus Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Growth Rate 2016-2026 (K MT)
Figure 7. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of DTaP
Figure 10. Product Picture of Td
Figure 11. Product Picture of Tdap
Figure 12. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Type in 2020
Figure 13. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Type (2016-2021)
Figure 14. Diphtheria, Pertussis, and Tetanus Vaccine Consumed in Hospitals
Figure 15. Global Diphtheria, Pertussis, and Tetanus Vaccine Market: Hospitals (2016-2021) & (K MT)
Figure 16. Diphtheria, Pertussis, and Tetanus Vaccine Consumed in Clinics
Figure 17. Global Diphtheria, Pertussis, and Tetanus Vaccine Market: Clinics (2016-2021) & (K MT)
Figure 18. Diphtheria, Pertussis, and Tetanus Vaccine Consumed in Vaccination Centers
Figure 19. Global Diphtheria, Pertussis, and Tetanus Vaccine Market: Vaccination Centers (2016-2021) & (K MT)
Figure 20. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Application (2016-2021)
Figure 21. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Application in 2020
Figure 22. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market by Company in 2020 ($ Million)
Figure 23. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Company in 2020
Figure 24. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Regions (2016-2021)
Figure 25. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Region in 2020
Figure 26. Americas Diphtheria, Pertussis, and Tetanus Vaccine Sales 2016-2021 (K MT)
Figure 27. Americas Diphtheria, Pertussis, and Tetanus Vaccine Revenue 2016-2021 ($ Millions)
Figure 28. APAC Diphtheria, Pertussis, and Tetanus Vaccine Sales 2016-2021 (K MT)
Figure 29. APAC Diphtheria, Pertussis, and Tetanus Vaccine Revenue 2016-2021 ($ Millions)
Figure 30. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales 2016-2021 (K MT)
Figure 31. Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue 2016-2021 ($ Millions)
Figure 32. Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales 2016-2021 (K MT)
Figure 33. Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue 2016-2021 ($ Millions)
Figure 34. Americas Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Country in 2020
Figure 35. Americas Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Country in 2020
Figure 36. Americas Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Type in 2020
Figure 37. Americas Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Application in 2020
Figure 38. United States Diphtheria, Pertussis, and Tetanus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 39. Canada Diphtheria, Pertussis, and Tetanus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 40. Mexico Diphtheria, Pertussis, and Tetanus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 41. Brazil Diphtheria, Pertussis, and Tetanus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 42. APAC Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Region in 2020
Figure 43. APAC Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Regions in 2020
Figure 44. APAC Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Type in 2020
Figure 45. APAC Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Application in 2020
Figure 46. China Diphtheria, Pertussis, and Tetanus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 47. Japan Diphtheria, Pertussis, and Tetanus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 48. Korea Diphtheria, Pertussis, and Tetanus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 49. Southeast Asia Diphtheria, Pertussis, and Tetanus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 50. India Diphtheria, Pertussis, and Tetanus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 51. Australia Diphtheria, Pertussis, and Tetanus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 52. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Country in 2020
Figure 53. Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Country in 2020
Figure 54. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Type in 2020
Figure 55. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Application in 2020
Figure 56. Germany Diphtheria, Pertussis, and Tetanus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 57. France Diphtheria, Pertussis, and Tetanus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 58. UK Diphtheria, Pertussis, and Tetanus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 59. Italy Diphtheria, Pertussis, and Tetanus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 60. Russia Diphtheria, Pertussis, and Tetanus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 61. Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Country in 2020
Figure 62. Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Country in 2020
Figure 63. Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Type in 2020
Figure 64. Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Application in 2020
Figure 65. Egypt Diphtheria, Pertussis, and Tetanus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 66. South Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 67. Israel Diphtheria, Pertussis, and Tetanus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 68. Turkey Diphtheria, Pertussis, and Tetanus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 69. GCC Country Diphtheria, Pertussis, and Tetanus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles


★調査レポート[世界のジフテリア・百日咳・破傷風ワクチン市場予測 2021年-2026年] (コード:LPI21MY1209)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のジフテリア・百日咳・破傷風ワクチン市場予測 2021年-2026年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆